PPAR Agonist Rosiglitazone Suppresses Renal mPGES-1/PGE2 Pathway in db/db Mice
Figure 2
Effect of Rosi treatment on the protein expressions of mPGES-1, COX-1, and COX-2 in the kidneys of db/db mice. (a) Western blots of mPGES-1, COX-1, COX-2, and -actin. (b) Densitometry of western blots. in each group. Data are mean ± SE.
